Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Lower Urinary Tract Symptoms

NCT07716774 is registered in ClinicalTrials.gov with Marmara University as lead sponsor.

NCT NCT07716774
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07716774 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Lower Urinary Tract Symptoms
Lead sponsor
Marmara University
Phase
Observational
Overall status
Active, not recruiting
Start date
July 1, 2026
Completion date
December 1, 2026
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lower urinary track symptoms, overactive bladder, sglt2 inhibitors